Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma

Human Pathology(2020)10.1016/j.humpath.2020.07.002Source: DataRank Database

Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma is a research paper published in Human Pathology (2020). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.95)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Daniel C. Ramirez ORCID,Wen Chen ORCID,Chao Lü ORCID,Lu Wang ORCID,Denise Frosina

Live enrichment

PubMed:32795465 PMC:PMC8366418 OpenAlex:https://openalex.org/W3048467195

NCI

Grant: P30 CA008748

NIH

FWCI

0.95

Citation Percentile

0.8%

Citation Trend

2021

2022

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8366418

publisherhttps://api.elsevier.com/content/article/PII:S0046817720301258?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0046817720301258?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.humpath.2020.07.002

Fields of Study

Bone Tumor Diagnosis and TreatmentsSarcoma Diagnosis and TreatmentOral and Maxillofacial Pathology

MeSH Terms

Progression-Free SurvivalAdultAgedAged, 80 and overChordomaChromosomes, Human, Pair 3FemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalHistone-Lysine N-MethyltransferaseSacrumSpinal Cord NeoplasmsTime FactorsBiomarkers, TumorTreatment OutcomeDisease ProgressionDNA MethylationLoss of HeterozygosityPolymorphism, Single NucleotideYoung Adult

Keywords

Loss of heterozygosityChordomaBiologyChromosomeGeneticsCancer researchPathologyMedicineGeneAlleleEpigeneticsRelapse-free SurvivalH3k36me3

Sustainable Development Goals

SDG 0: Good health and well-being